Positron emission tomography: Useful in detecting metastatic cancer of unknown primary site

Singapore Medical Journal

Volumn 46, Issue 6, 2005, Pages 302-303

  Ruiz Ruiz, Franciso J ^a   Saenz Abad, D ^a   Hualde Enguita, A M ^b   Morales Rull, J L ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^b Department of Orthopaedic Surgery ^*

Author keywords

Cancer; Metastases; Positron emission tomography; Unknown primary neoplasm

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IBUPROFEN;

ADULT; BONE BIOPSY; BONE METASTASIS; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; FEMALE; HUMAN; HUMAN TISSUE; LOW BACK PAIN; LUNG CANCER; OSTEOLYSIS; PELVIS RADIOGRAPHY; POSITRON EMISSION TOMOGRAPHY; REVIEW; SENSITIVITY AND SPECIFICITY; THORAX RADIOGRAPHY;

FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; NEOPLASMS, UNKNOWN PRIMARY; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 19944372764     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (8)

1. Pavlidis N, Briasoulis E, Hainsworth J, Greco FA. Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer 2003; 39:1990-2005.
2. Kole AC, Nieweg OE, Pruim J, Hoekstra HJ, Koops HS, Roodenburg JL, et al. Detection of unknown occult primary tumors using positron emission tomography. Cancer 1998; 82:1160-6.
3. Bohuslavizki KH, Klutmann S, Kroger S, Sonnemann U, Buchen R, Werner JA, et al. FDG PET detection of unknown primary tumors. J Nucl Med 2000; 41:816-22.
4. Rades D, Kuhnel G, Wildfang I, Borner AR, Schmoll HJ, Knapp W. Localised disease in cancer of unknown primary (CUP): the value of positron emission tomography (PET) for individual therapeutic management. Ann Oncol 2001; 12:1605-9.
5. Cook GJ, Fogelman I, Maisey MN. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation. Semin Nucl Med 1996; 26:308-14.
6. Gupta N, Gill H, Graeber G, Bishop H, Hurst J, Stephens T. Dynamic positron emission tomography with F-18 fluorodeoxyglucose imaging in differentiation of benign from malignant lung/mediastinal lesions. Chest 1998; 114:1105-11.
7. Sasaki M, Kuwabara Y, Yoshida T, Nakagawa M, Koga H, Hayashi K, et al. Comparison of MET-PET and FDG-PET for differentiation between benign lesions and maligmant tumors of the lung. Ann Nucl Med 2001; 15:425-31.
8. Gugiatti A, Grimaldi A, Rossetti C, Lucignani G, De Marchis D, Borgonovi E, et al. Economic analyses on the use of positron emission tomography for the work-up of solitary pulmonary nodules and for staging patients with non-small-cell-lung-cancer in Italy. Q J Nucl Med Mol Imaging 2004; 48:49-61.